Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.

Abstract

PURPOSE To identify, with noninvasive imaging, the zone of radiopharmaceutical uptake after combination therapy with radiofrequency (RF) ablation and intravenous administration of technetium 99m ((99m)Tc) liposomal doxorubicin in a small-animal tumor model, and to quantify and correlate the uptake by using imaging and tissue counting of intratumoral… (More)
DOI: 10.1148/radiol.10090714

Topics

Cite this paper

@article{Head2010CombinationRA, title={Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.}, author={Hayden W Head and Gerald D. Dodd and Ande Bao and Anuradha Soundararajan and Xavier Garcia-Rojas and Thomas J. Prihoda and Linda M. McManus and Beth Ann Goins and Cristina A Santoyo and William Phillips}, journal={Radiology}, year={2010}, volume={255 2}, pages={405-14} }